tradingkey.logo

Cibus Inc

CBUS
2.080USD
-0.160-7.14%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
109.34MMarktkapitalisierung
VerlustKGV TTM

Cibus Inc

2.080
-0.160-7.14%

mehr Informationen über Cibus Inc Unternehmen

Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.

Cibus Inc Informationen

BörsenkürzelCBUS
Name des UnternehmensCibus Inc
IPO-datumJul 20, 2017
CEOBeetham (Peter Ronald)
Anzahl der mitarbeiter157
WertpapierartOrdinary Share
GeschäftsjahresendeJul 20
Addresse6455 Nancy Ridge Drive
StadtSAN DIEGO
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl92121
Telefon18584500008
Websitehttps://www.cibus.com/
BörsenkürzelCBUS
IPO-datumJul 20, 2017
CEOBeetham (Peter Ronald)

Führungskräfte von Cibus Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.96M
+333333.00%
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
382.44K
--
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
127.67K
+127669.00%
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
105.48K
+105480.00%
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
40.20K
+32490.00%
Mr. Mark Finn
Mr. Mark Finn
Lead Independent Director
Lead Independent Director
--
--
Mr. Jean-Pierre Lehmann
Mr. Jean-Pierre Lehmann
Independent Director
Independent Director
--
--
Dr. Keith A. Walker, Ph.D.
Dr. Keith A. Walker, Ph.D.
Independent Director
Independent Director
--
--
Dr. Greg Gocal, Ph.D.
Dr. Greg Gocal, Ph.D.
Co-Founder, Executive Vice President, Chief Scientific Officer
Co-Founder, Executive Vice President, Chief Scientific Officer
--
--
Mr. Cornelis (Carlo) Broos
Mr. Cornelis (Carlo) Broos
Chief Financial Officer
Chief Financial Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.96M
+333333.00%
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
382.44K
--
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
127.67K
+127669.00%
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
105.48K
+105480.00%
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
40.20K
+32490.00%
Mr. Mark Finn
Mr. Mark Finn
Lead Independent Director
Lead Independent Director
--
--

Umsatzaufteilung

FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2023
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United States
615.00K
0.00%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Sat, Feb 7
Aktualisiert: Sat, Feb 7
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Riggs (Rory B)
22.03%
Fidelity Management & Research Company LLC
10.81%
JPL Investments SA
2.47%
The Vanguard Group, Inc.
1.83%
Vantage Consulting Group, Inc.
1.68%
Andere
61.17%
Aktionäre
Aktionäre
Anteil
Riggs (Rory B)
22.03%
Fidelity Management & Research Company LLC
10.81%
JPL Investments SA
2.47%
The Vanguard Group, Inc.
1.83%
Vantage Consulting Group, Inc.
1.68%
Andere
61.17%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
24.88%
Investment Advisor
13.88%
Corporation
2.53%
Investment Advisor/Hedge Fund
2.38%
Hedge Fund
0.98%
Family Office
0.16%
Research Firm
0.14%
Venture Capital
0.10%
Bank and Trust
0.07%
Andere
54.87%

Institutionelle Beteiligung

Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
155
11.44M
29.24%
--
2025Q3
160
11.44M
29.36%
-1.15M
2025Q2
160
12.59M
24.13%
+683.12K
2025Q1
154
11.90M
30.83%
+1.84M
2024Q4
150
9.30M
35.60%
+430.74K
2024Q3
137
8.87M
33.20%
+582.16K
2024Q2
125
8.28M
27.75%
+2.07M
2024Q1
106
6.21M
28.39%
+246.00K
2023Q4
96
5.70M
24.18%
+956.24K
2023Q3
100
4.74M
25.36%
+638.98K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Riggs (Rory B)
14.63M
27.75%
+11.68M
+396.82%
Jun 09, 2025
Fidelity Management & Research Company LLC
7.34M
13.93%
+174.27K
+2.43%
Sep 30, 2025
JPL Investments SA
1.67M
3.18%
-12.28K
-0.73%
Mar 24, 2025
The Vanguard Group, Inc.
962.37K
1.83%
+106.22K
+12.41%
Sep 30, 2025
Vantage Consulting Group, Inc.
1.14M
2.17%
--
--
Sep 30, 2025
Beetham (Peter Ronald)
382.44K
0.73%
--
--
Mar 24, 2025
Gocal (Gregory Francis William)
374.84K
0.71%
+60.00K
+19.06%
Mar 24, 2025
BlackRock Institutional Trust Company, N.A.
282.15K
0.54%
-174.06K
-38.15%
Sep 30, 2025
Certior Financial Group, LLC
184.79K
0.35%
+11.23K
+6.47%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares Micro-Cap ETF
0.01%
iShares Russell 2000 Value ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Russell 2000 ETF
0%
iShares Micro-Cap ETF
Anteil0.01%
iShares Russell 2000 Value ETF
Anteil0%
Global X Russell 2000 ETF
Anteil0%
Proshares Ultra Russell 2000
Anteil0%
ProShares UltraPro Russell2000
Anteil0%
ProShares Hedge Replication ETF
Anteil0%
iShares Core S&P Total U.S. Stock Market ETF
Anteil0%
iShares Russell 2000 ETF
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Jun 01, 2023
Merger
5→1
Apr 07, 2023
Merger
10→1
Datum
Ex-Dividendentag
Art
Verhältnis
Jun 01, 2023
Merger
5→1
Apr 07, 2023
Merger
10→1
KeyAI